Logo Université de Strasbourg


Sur ce site

Sur le Web du CNRS

Accueil > Infos et Pages pratiques > Annonces de rencontres scientifiques > À l’étranger > Nature Chemical Biology Symposium 2011 : Cancer Chemical Biology

Nature Chemical Biology Symposium 2011 : Cancer Chemical Biology

October 20-22, 2011, Royal Sonesta Hotel Boston, Cambridge, MA, USA

May 17, 2011

2011 celebrates the tenth anniversary of the approval of Imatinib. The drug is one of the first major success stories for rational drug design, and serves to highlight the contributions of chemical biology to cancer therapeutics and in understanding biological processes. The 2011 symposium will explore the chemical biology of cancer in terms of therapeutic opportunities and a comprehensive view of cancer biology. The three-day meeting will comprise a series of six scientific sessions that highlight

  • The pathways that contribute to cancer and its treatment including cell death, epigenetic regulation, and metabolism.
  • The chemical biology approaches of imaging and chemical genetics.


James Bradner (Dana-Farber Cancer Institute & Harvard Medical School, USA)
Lewis Cantley (Harvard Medical School, USA)
Jennifer Cochran (Stanford University, USA)
Benjamin Cravatt (The Scripps Research Institute, USA)
Peter Finan (Novartis Institutes for BioMedical Research, Inc., USA)
Robert Langer (Massachusetts Institute of Technology, USA)
Tom Muir (The Rockefeller University, USA)
Victoria Richon (Epizyme, Inc., USA)
Neal Rosen (Sloan Kettering Institute, USA)
Stuart Schreiber (Harvard University & The Broad Institute, USA)
Yigong Shi (Tsinghua University, China)
Brent Stockwell (Columbia University, USA)
Shin-San Michael Su (Agios Pharmaceuticals, USA)
Alice Ting (Massachusetts Institute of Technology, USA)
Roger Tsien (University of California, San Diego, USA)
Herbert Waldmann (Max Planck Institute of Molecular Physiology, Germany)
Loren Walensky (Dana-Farber Cancer Institute & Harvard Medical School, USA)
Ralph Weissleder (Massachusetts General Hospital, USA)
James Wells (University of California, San Francisco, USA)


Mirella Bucci (Nature Chemical Biology, USA)
Kimberly Stegmaier (Harvard Medical School & Dana-Farber Cancer Institute, USA)
Gregory L. Verdine (Harvard University & Dana-Farber Cancer Institute, USA)


  • Session 1 : Cell Death
  • Session 2 : Epigenetics
  • Session 3 : Imaging
  • Session 4 : Metabolism
  • Session 5 : Chemical Genetics
  • Session 6 : Non-traditional Therapeutics


Application deadline : July 14, 2011
Submit your abstract no later than July 14, 2011

- For more information and to apply visit the Symposium website